This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Radiotherapy

Authoring team

A majority of malignant melanomas are resistant to radiotherapy but good results have been reported from the primary treatment of lentigo maligna melanoma and ocular melanoma (1).

The use of radiotherapy is therefore on a symptomatic basis.

  • treatment of painful metastatic bone disease and brain secondaries
  • sometimes used to palliate disease at many sites, particularly cutaneous metastatic deposits
  • response rate is 40% at best

Reference:

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.